Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 062640
Company: ACS DOBFAR
Company: ACS DOBFAR
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CEFTAZIDIME | CEFTAZIDIME | 500MG/VIAL | INJECTABLE;INJECTION | Discontinued | None | No | No |
| CEFTAZIDIME | CEFTAZIDIME | 1GM/VIAL | INJECTABLE;INJECTION | Prescription | AP | No | Yes |
| CEFTAZIDIME | CEFTAZIDIME | 2GM/VIAL | INJECTABLE;INJECTION | Prescription | AP | No | Yes |
| CEFTAZIDIME | CEFTAZIDIME | 6GM/VIAL | INJECTABLE;INJECTION | Prescription | AP | No | Yes |